Syndrome News and Research

RSS

Childhood asthma is not a risk factor for COVID-19

A new study provides new insights on the association of childhood asthma and COVID-19.

26 Sep 2021

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

24 Sep 2021

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

A recent study supports the efficacy of the mRNA-1273 vaccine in preventing COVID-19 illness and disease severity.

24 Sep 2021

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein

A new study presents initial results from a randomized, placebo-controlled phase 1/2 trial in Thailand.

24 Sep 2021

COVID-19 vaccination status among US college students

A new study has been published to study the correlations of COVID-19 vaccination status among college students.

24 Sep 2021

Presumed immunity in US remains below the threshold sufficient to disrupt SARS-CoV-2 transmission

Researchers have investigated publicly available data published to investigate the proportion of the US population that has become immune to SARS-CoV-2.

24 Sep 2021

No excess mortality during the Delta variant era in US state with high vaccination rates

Researchers have investigated the number of excess deaths during the initial spread of the Delta variant.

24 Sep 2021

A daily pill to treat covid could be just months away, scientists say

Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to the emergency room.

24 Sep 2021

Human milk antibodies elicited by vaccination show reduced activity against SARS-CoV-2 VoCs

In a study recently published on the medRxiv* preprint server, scientists from Singapore have assessed the levels of IgA-specific anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the breast milk of women recently immunized with the second dose of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine.

24 Sep 2021

Effect of prior SARS-CoV-2 infection on post-vaccination SARS-CoV-2 spike IgG antibodies

Natural infection or vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confer considerable protection against reinfection and reduce the risk of severe Coronavirus disease 2019 (COVID-19) outcomes.

24 Sep 2021

Using air filtration to remove airborne SARS-CoV-2 and other microbial aerosols in COVID wards

University of Cambridge researchers conducted a study in two repurposed COVID-19 units in Addenbrooke’s Hospital, Cambridge, UK, between January and February 2021. During this time, the alpha variant (lineage B1.1.7) accounted for >80% of the circulating SARS-CoV-2. This study, posted to the medRxiv* preprint server, aimed to provide evidence of the removal of SARS-CoV-2 and microbial bioaerosols using portable air filters with UV sterilization.

24 Sep 2021

Potential covalent SARS-CoV-2 spike protein inhibitors

People with natural immunity and subsequent mRNA vaccination can neutralize viral particles capable of resisting vaccine-induced antibodies

New research suggests SARS-CoV-2 spike protein substitution mutations can create a replication-defective viral particle that makes the virus resistant to vaccine-induced antibodies.

23 Sep 2021

Syndrome News and Research

Childhood asthma is not a risk factor for COVID-19

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein

COVID-19 vaccination status among US college students

Presumed immunity in US remains below the threshold sufficient to disrupt SARS-CoV-2 transmission

No excess mortality during the Delta variant era in US state with high vaccination rates

A daily pill to treat covid could be just months away, scientists say

Human milk antibodies elicited by vaccination show reduced activity against SARS-CoV-2 VoCs

Effect of prior SARS-CoV-2 infection on post-vaccination SARS-CoV-2 spike IgG antibodies

Using air filtration to remove airborne SARS-CoV-2 and other microbial aerosols in COVID wards

Potential covalent SARS-CoV-2 spike protein inhibitors

How SARS-CoV-2 spike binds to multiple host receptors

COVID-19 vaccination and lactation

Design of mRNA vaccines to combat COVID-19

COVID-19 vaccination eases healthcare demand

COVID-19 transmission is higher with warm weather and increased visits to indoors public places, study finds

New methodology for evaluating transmissibility and competitive advantages of co-circulating SARS-CoV-2 variants

Study finds spousal similarities in the incidences of some diseases

People with natural immunity and subsequent mRNA vaccination can neutralize viral particles capable of resisting vaccine-induced antibodies

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News